Related Experiment Video
Updated: Sep 11, 2026

Non-invasive Assessment of Microvascular and Endothelial Function
Published on: January 29, 2013
Non-invasive measures of coronary microcirculation: Taking the long road to the clinic
Kieran S Chung1, Patricia K Nguyen2,3
1Cardiology Section, Veterans Affairs Palo Alto Health Care Administration, Palo Alto, CA, USA.
Insights
Current non-invasive methods struggle to distinguish coronary microvascular disease (CMD) from epicardial stenosis. Evaluating intramyocardial blood volume aids CMD diagnosis alongside epicardial disease, improving patient management.
Area of Science:
- Cardiology
- Medical Imaging
- Vascular Biology
Background:
- Coronary microvascular disease (CMD) is a significant cause of morbidity and mortality.
- Current non-invasive diagnostic tools cannot reliably differentiate CMD from obstructive epicardial stenosis.
Discussion:
- Intramyocardial blood volume assessment shows promise as a surrogate marker for microvascular health.
- This method can diagnose CMD even when epicardial disease is present.
- Limitations exist, particularly in early-stage CMD detection.
Key Insights:
- Non-invasive strategies for CMD diagnosis remain a clinical challenge.
- Intramyocardial blood volume evaluation offers a potential pathway for diagnosing concurrent CMD and epicardial stenosis.
- Further research and technological development are crucial.
Outlook:
- Advancing non-invasive diagnostic tools for CMD is essential for improved patient outcomes.
- Investment in bedside technologies for CMD assessment is needed.
- Enhanced diagnostic capabilities will facilitate more targeted therapeutic interventions.
Abstract:
Although coronary microvascular disease is now a well-recognized entity that is associated with significant morbidity and mortality, current non-invasive strategies cannot differentiate between coronary microvascular disease (CMD) and obstructive epicardial stenosis. While the evaluation of intramyocardial blood volume as a surrogate measure for microvascular health may have limited sensitivity in early-stage disease, this strategy does enable the diagnosis of CMD in the presence of concurrent epicardial disease, bringing us one step further toward improving the management of this disease. Herein, we discuss the advantages and limitations of current non-invasive measures of CMD and the need for further investment in bringing these technologies to the bedside.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

